These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 3932639)

  • 1. Dose dependent pharmacokinetics of nitroglycerin after multiple intravenous infusions in healthy volunteers.
    Noonan PK; Williams RL; Benet LZ
    J Pharmacokinet Biopharm; 1985 Apr; 13(2):143-57. PubMed ID: 3932639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and pharmacodynamics of nitroglycerin and its dinitrate metabolites in conscious dogs: intravenous infusion studies.
    Lee FW; Salmonson T; Benet LZ
    J Pharmacokinet Biopharm; 1993 Oct; 21(5):533-50. PubMed ID: 8145130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitroglycerin pharmacokinetics after intravenous infusion in normal subjects.
    McNiff EF; Yacobi A; Young-Chang FM; Golden LH; Goldfarb A; Fung HL
    J Pharm Sci; 1981 Sep; 70(9):1054-8. PubMed ID: 6101155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitroglycerin dinitrate metabolites do not affect the pharmacokinetics and pharmacodynamics of nitroglycerin in the dog: a preliminary report.
    Lee FW; Hu J; Metzler CH; Benet LZ
    J Pharmacokinet Biopharm; 1993 Apr; 21(2):163-73. PubMed ID: 8229678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clevidipine: a review of its use in the management of acute hypertension.
    Deeks ED; Keating GM; Keam SJ
    Am J Cardiovasc Drugs; 2009; 9(2):117-34. PubMed ID: 19331440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variable glyceryl dinitrate formation as a function of route of nitroglycerin administration.
    Noonan PK; Benet LZ
    Clin Pharmacol Ther; 1987 Sep; 42(3):273-7. PubMed ID: 3113806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies of the bioavailability of nitroglycerin from a transdermal therapeutic system (Nitroderm TTS).
    Imhof PR; Vuillemin T; Gérardin A; Racine A; Müller P; Follath F
    Eur J Clin Pharmacol; 1984; 27(1):7-12. PubMed ID: 6436032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of nitroglycerin after parenteral and oral dosing in the rat.
    Fung HL; Ogata H; Kamiya A; Maier GA
    J Pharm Sci; 1984 Jul; 73(7):873-9. PubMed ID: 6432996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steady state pharmacokinetic haemodynamic studies of intravenous nitroglycerin in congestive cardiac failure.
    Armstrong PW; Watts DG; Moffat JA
    Br J Clin Pharmacol; 1983 Oct; 16(4):385-90. PubMed ID: 6414501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution and metabolism of nitroglycerin and its metabolites in vascular beds of sheep.
    Cossum PA; Roberts MS; Yong AC; Kilpatrick D
    J Pharmacol Exp Ther; 1986 Jun; 237(3):959-66. PubMed ID: 3086541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of infusion administration set on the delivery rate and plasma concentration of nitroglycerin in dogs.
    McNiff EF; Lai CM; Look ZM; Yacobi A; Fung HL
    J Pharm Sci; 1985 Jul; 74(7):774-6. PubMed ID: 3928871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma concentrations and haemodynamic effects of nitroglycerin during and after intravenous infusion in healthy volunteers.
    Imhof PR; Sieber A; Hodler J; Müller P; Ott B; Fankhauser P; Chu LC; Gérardin A
    Eur J Clin Pharmacol; 1982; 23(2):99-106. PubMed ID: 6814928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolerance development and arterial and venous tissue-/plasma levels of glyceryl trinitrate and glyceryl dinitrate in patients treated with nitroglycerin infusion.
    Torfgård KE; Svedjeholm R; Håkansson E; Ahlner J
    Arzneimittelforschung; 1995 Sep; 45(9):963-6. PubMed ID: 7488313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of isosorbide dinitrate in healthy volunteers after 24-hour intravenous infusion.
    Bergami A; Bernasconi R; Caccia S; Leopaldi D; Mizrahi J; Sardina M; Urso R; Warrington SJ; Latini R
    J Clin Pharmacol; 1997 Sep; 37(9):828-33. PubMed ID: 9549637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the liver in the disposition of intravenous nitroglycerin in the rat.
    Blei AT; Gottstein J; Fung HL
    Biochem Pharmacol; 1984 Aug; 33(16):2681-6. PubMed ID: 6431989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glyceryl-1-nitrate pharmacokinetics in healthy volunteers.
    Laufen H; Leitold M
    Br J Clin Pharmacol; 1987 Mar; 23(3):287-93. PubMed ID: 3105569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specialized delivery systems for intravenous nitroglycerin. Are they necessary?
    Young JB; Pratt CM; Farmer JA; Luck JC; Fennell WH; Roberts R
    Am J Med; 1984 Jun; 76(6A):27-37. PubMed ID: 6430075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and pharmacodynamics of glyceryl trinitrate and its two dinitrate metabolites in conscious dogs.
    Lee FW; Salmonson T; Metzler CH; Benet LZ
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1222-9. PubMed ID: 2124621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma concentrations of glyceryl trinitrate and its dinitrate metabolites after sublingual administration to volunteers. Simultaneous determination of glyceryl trinitrate and its dinitrate metabolites.
    Jensen KM; Dahl JB
    Arzneimittelforschung; 1994 Aug; 44(8):951-3. PubMed ID: 7945539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interpretation of nitrate plasma concentrations. Effect of cardiac output on nitroglycerin pharmacokinetics in experimental animals.
    Fung HL; Blei A; Chong S
    Eur Heart J; 1988 Jan; 9 Suppl A():39-43. PubMed ID: 3137071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.